United Therapeutics (UTHR) Non-Current Assets (2009 - 2026)

United Therapeutics (UTHR) has 18 years of Non-Current Assets data on file, last reported at $3.8 billion in Q1 2026.

• For the quarter ending Q1 2026, Non-Current Assets rose 1.0% year-over-year to $3.8 billion; the trailing twelve-month figure through Mar 2026 stood at $16.0 billion (up 149.34% YoY), and the FY2025 full-year result was $4.2 billion, up 19.7% from the prior year.
• Non-Current Assets fell to $3.8 billion in Q1 2026, from $4.2 billion in the prior quarter.
• In the past five years, Non-Current Assets ranged from a high of $4.2 billion in Q4 2025 to a low of -$4.0 billion in Q3 2024.
• A 5-year average of $3.0 billion and a median of $3.5 billion in 2023 frame the typical range for Non-Current Assets.
• Across the five-year window, Non-Current Assets tumbled 212.15% in 2024 and surged 196.48% in 2025, its largest moves.
• Tracing UTHR's Non-Current Assets over 5 years: stood at $2.7 billion in 2022, then surged by 35.73% to $3.6 billion in 2023, then fell by 3.48% to $3.5 billion in 2024, then grew by 19.7% to $4.2 billion in 2025, then dropped by 8.03% to $3.8 billion in 2026.
• Business Quant data shows UTHR's Non-Current Assets at $3.8 billion in Q1 2026, $4.2 billion in Q4 2025, and $3.9 billion in Q3 2025.